Active-Targeting NIR-II Phototheranostics in Multiple Tumor Models Using Platelet-Camouflaged Nanoprobes
Xiaorui Geng,Duyang Gao,Dehong Hu,Quanhong Liu,Chengbo Liu,Zhen Yuan,Xuanjun Zhang,Xin Liu,Zonghai Sheng,Xiaobing Wang,Hairong Zheng
DOI: https://doi.org/10.1021/acsami.0c16872
2020-12-03
Abstract:Cancer phototheranostics in the second near-infrared window (NIR-II, 1000–1700 nm) has recently attracted much attention owing to its high efficacy and good safety compared with that in the first near-infrared window (NIR-I, 650–950 nm). However, the lack of theranostic nanoagents with active-targeting features limits its further application in cancer precision therapies. Herein, we constructed platelet-camouflaged nanoprobes with active-targeting characteristics for NIR-II cancer phototheranostics. The as-prepared biomimetic nanoprobes can not only escape phagocytosis by macrophages but also specifically bind to CD44 on the surface of most cancer cells. We evaluated the active-targeting performance of biomimetic nanoprobes in pancreatic cancer, breast cancer, and glioma mouse models and achieved NIR-II photoacoustic imaging with a high signal-to-background ratio and photothermal treatment with excellent tumor growth inhibition. Our results show the great potential of platelet-camouflaged nanoprobes with NIR-II active-targeting features for cancer precision diagnosis and efficient therapies.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c16872?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c16872</a>.Summary of probes for photoacoustic imaging combined with photothermal therapy under 1064 nm laser irradiation; zeta potential of LIPO-1048, BLIPO-1048, and PM; CD spectra of BLIPO-1048 and PM; relationship between the concentration of IR 1048 and the fluorescence intensity; standard curve of IR 1048 in 90% dimethyl sulfoxide solution; hydrodynamic diameters of BLIPO-1048 in H<sub>2</sub>O, PBS, and 10% FBS; drug release profiles of BLIPO-1048 in H<sub>2</sub>O, PBS, and 10% FBS; photothermal conversion efficiencies of IR 1048, LIPO-1048, and BLIPO-1048; photothermal stability of BLIPO-1048 and IR 1048; CLSM images of primary macrophages treated with LIPO-1048 and BLIPO-1048; flow cytometry analysis of RAW264.7 cells treated with LIPO-1048 and BLIPO-1048; flow cytometry analysis and fluorescence intensity of C6 cells treated with LIPO-1048 and BLIPO-1048; and hemolysis rate of BLIPO-1048 (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c16872/suppl_file/am0c16872_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology